The Discounted Cash Flow (DCF) valuation of Haemonetics Corp (HAE) is 78.11 USD. With the latest stock price at 83.49 USD, the upside of Haemonetics Corp based on DCF is -6.4%.
Based on the latest price of 83.49 USD and our DCF valuation, Haemonetics Corp (HAE) is a sell. selling HAE stocks now will result in a potential gain of 6.4%.
| Range | Selected | |
| WACC / Discount Rate | 6.2% - 8.0% | 7.1% |
| Long-term Growth Rate | 2.0% - 4.0% | 3.0% |
| Fair Price | 49.57 - 155.08 | 78.11 |
| Upside | -40.6% - 85.7% | -6.4% |